Kim De Keersmaecker: advisors and students

Academic Ancestry

a person in the record

Kim De Keersmaecker

Researcher

Supervised 11 doctoral students between 2017 and 2026. Linked to Wikidata, ORCID, and Scopus.

Open the full sheet Cite Data

Two steps up and one down. Dashed lines come from thesis records. The full sheet opens at four up and two down.

How to read the markscited by a repository's recordstated by Wikidata or indexed by OpenAlexclaimed on an ORCID list, or inferred

Students11

cited by a thesis record
Paulien Verstraete “Serine/glycine synthesis addiction in acute lymphoblastic leukemia and resulting therapeutic opportunities”
2026 · doctoral
cited by a thesis record
Xander Janssens “Unravelling the role of synonymous mutations in cancer”
2025 · doctoral
cited by a thesis record
Linde Van Aerschot “THE ROLE OF NKX2-1 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND HOW IT COOPERATES WITH THE RPL10 R98S MUTATION”
2024 · doctoral
cited by a thesis record
Elien Heylen “Oncogenic drivers and therapeutic targeting of serine and glycine synthesis in cancer”
2023 · doctoral
cited by a thesis record
Samantha Zaunz “In search of ex vivo hematopoietic stem cell culture models and the role of APEX1 in adult hematopoietic stem and progenitor cell expansion.”
2023 · doctoral
cited by a thesis record
Benno Verbelen “Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells.”
2022 · doctoral
cited by a thesis record
Stijn Vereecke “How Ribosomal Protein Mutations Translate Cancer”
2021 · doctoral
cited by a thesis record
Shauni Lien Geeraerts “Metabolic rewiring in cancer: Pharmacological targeting of serine/glycine synthesis addicted cancers”
2020 · doctoral
cited by a thesis record
N. Kint “In search of novel working mechanisms of proteasome inhibitors in multiple myeloma”
2019 · doctoral
cited by a thesis record
T. Girardi “How the RPL10 R98S mutation translates T-cell acute lymphoblastic leukemia”
2017 · doctoral
cited by a thesis record
I. Hofman “Ribosomal defects in multiple myeloma: RPL5 is a candidate tumor suppressor”
2017 · doctoral

The line above and below

Below them, within 3 steps, the record reaches 11 people: 11 cited by thesis records.

Education and career5

From Wikidata, shown separately from the thesis records. Each place opens its Wikidata item.

2000 to 2004
Katholieke Universiteit Leuven
studied
2004 to 2008
Katholieke Universiteit Leuven
studied
2008 to 2010
Columbia University
worked
2008 to 2010
Research Foundation - Flanders
worked
from 2013
Katholieke Universiteit Leuven
worked